Cargando…

PROTAC vaccine: A new way to live attenuated vaccines

Detalles Bibliográficos
Autores principales:	Li, Zhen, Bai, Haiqing, Xi, Xuetong, Tian, Wen‐xia, Zhang, John Z.H., Zhou, Demin, Si, Longlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593255/ https://www.ncbi.nlm.nih.gov/pubmed/36281705 http://dx.doi.org/10.1002/ctm2.1081

Ejemplares similares

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Adult vaccination in India: status and the way forward
por: Lahariya, Chandrakant, et al.
Publicado: (2019)

Commentary: PROTACs make undruggable targets druggable: Challenge and opportunity
por: Lu, Bin, et al.
Publicado: (2021)

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
por: Poehling, Katherine A, et al.
Publicado: (2018)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward
por: Zhao, Xue-Lian, et al.
Publicado: (2023)

An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
por: Zhang, Yuzhu, et al.
Publicado: (2022)

The round trip model for severe herpes zoster caused by live attenuated varicella vaccine virus
por: Grose, Charles, et al.
Publicado: (2020)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

On the way to developing AAV-based vaccines as novel tools for cancer immunotherapy
por: Hacker, Ulrich T.
Publicado: (2023)

Current efforts towards safe and effective live attenuated vaccines against African swine fever: challenges and prospects
por: Wang, Tao, et al.
Publicado: (2021)

DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

Vaccine safety concerns: Should we be changing the way we support immunization?
por: MacDonald, Noni E, et al.
Publicado: (2020)

Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward
por: Assiri, Abdullah, et al.
Publicado: (2021)

A step forward for an attenuated blood-stage malaria vaccine
por: Burns, James M.
Publicado: (2018)

Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation
por: Gershon, Anne A., et al.
Publicado: (2022)

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
por: Halstead, Scott B.
Publicado: (2018)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

PROTAC-DB 2.0: an updated database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2022)

Long-lived immunity to genetically detoxified pertussis vaccines
por: Locht, Camille
Publicado: (2021)

Fairer financing of vaccines in a world living with COVID-19
por: Megiddo, Itamar, et al.
Publicado: (2020)

Paving the way to a new class of efficient and safe tuberculosis vaccines: The role of c-di-AMP in Mycobacterium tuberculosis immunity and virulence
por: El Zowalaty, Mohamed E., et al.
Publicado: (2022)

PROTACs in gastrointestinal cancers
por: Chen, Yu, et al.
Publicado: (2022)

Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward
por: Lawal, Lukman, et al.
Publicado: (2022)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

Australian chiropractic sports medicine: half way there or living on a prayer?
por: Pollard, Henry, et al.
Publicado: (2007)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
por: Shin, Robert K., et al.
Publicado: (2021)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

Vaccine hesitancy – a potential threat to the achievements of vaccination programmes in Africa
por: Cooper, Sara, et al.
Publicado: (2018)

Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination
por: Price, Nathan B., et al.
Publicado: (2021)

The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines
por: Mok, Darren Z. L., et al.
Publicado: (2020)

New ways for an old cation
por: Diener, Martin
Publicado: (2020)

Recent advancements in combination subunit vaccine development
por: Tan, Ming, et al.
Publicado: (2016)

Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan
por: Lin, Ya Wen, et al.
Publicado: (2021)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

New ways and new hopes for IGR development
por: Jindra, Marek
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgdtv33np4kgk3471mgbb21aqo